Cellular and molecular mechanisms of oroxylin A in cancer therapy: Recent advances

被引:2
作者
Wang, Peng-Xin [1 ,2 ]
Mu, Xiao-Nan [3 ]
Huang, Shu-Hong [4 ]
Hu, Kang [5 ]
Sun, Zhi-Gang [1 ]
机构
[1] Shandong First Med Univ, Cent Hosp, Dept Thorac Surg, Jinan 250013, Shandong, Peoples R China
[2] Jining Med Univ, Med Coll, Jining 272067, Shandong, Peoples R China
[3] Shandong First Med Univ, Cent Hosp, Hlth Care & Geriatr Ward 1, Jinan 250013, Shandong, Peoples R China
[4] Shandong First Med Univ, Shandong Prov Hosp, Sch Clin & Basic Med Sci, Jinan 250062, Shandong, Peoples R China
[5] Soochow Univ, Suzhou Med Coll, Affiliated Hosp 1, Dept Thorac Surg, Suzhou 215000, Jiangsu, Peoples R China
关键词
Oroxylin A; Cancer; Apoptosis; Metastasis; Molecular mechanisms; Traditional Chinese medicine; NF-KAPPA-B; CHRONIC MYELOGENOUS LEUKEMIA; PPAR-GAMMA; MULTIDRUG-RESISTANCE; SIGNALING PATHWAY; P-GLYCOPROTEIN; MITOCHONDRIAL TRANSLOCATION; GLUCOSE-METABOLISM; INDUCED APOPTOSIS; CARCINOMA CELLS;
D O I
10.1016/j.ejphar.2024.176452
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Seeking an effective and safe scheme is the common goal of clinical treatment of tumor patients. In recent years, traditional Chinese medicine has attracted more and more attention in order to discover new drugs with good anti -tumor effects. Oroxylin A (OA) is a compound found in natural Oroxylum indicum and Scutellaria baicalensis Georgi plants and has been used in the treatment of various cancers. Studies have shown that OA has a wide range of powerful biological activities and plays an important role in neuroprotection, anti -inflammation, anti -virus, anti -allergy, anti -tumor and so on. OA shows high efficacy in tumor treatment. Therefore, it has attracted great attention of researchers all over the world. This review aims to discuss the anti -tumor effects of OA from the aspects of cell cycle arrest, induction of cell proliferation and apoptosis, induction of autophagy, anti -inflammation, inhibition of glycolysis, angiogenesis, invasion, metastasis and reversal of drug resistance. In addition, the safety and toxicity of the compound were also discussed. As a next step, to clarify the benefits and adverse effects of Oroxylin A in cancer patients further experiments, especially clinical trials, are needed.
引用
收藏
页数:15
相关论文
共 50 条
  • [21] Sesquiterpenoid lactones as potential anti-cancer agents: an update on molecular mechanisms and recent studies
    Praveen Dhyani
    Priyanka Sati
    Eshita Sharma
    Dharam Chand Attri
    Amit Bahukhandi
    Bekzat Tynybekov
    Agnieszka Szopa
    Javad Sharifi-Rad
    Daniela Calina
    Hafiz A. R. Suleria
    William C. Cho
    Cancer Cell International, 22
  • [22] Nobiletin in Cancer Therapy; Mechanisms and Therapy Perspectives
    Moazamiyanfar, Reza
    Rezaei, Sepideh
    Aliashrafzadeh, Hasan
    Rastegar-Pouyani, Nima
    Jafarzadeh, Emad
    Mouludi, Kave
    Khodamoradi, Ehsan
    Zhaleh, Mohsen
    Taeb, Shahram
    Najafi, Masoud
    CURRENT PHARMACEUTICAL DESIGN, 2023, 29 (22) : 1713 - 1728
  • [23] Molecular mechanisms of action of epigallocatechin gallate in cancer: Recent trends and advancement
    Aggarwal, Vaishali
    Tuli, Hardeep Singh
    Tania, Mousumi
    Srivastava, Saumya
    Ritzer, Erin E.
    Pandey, Anjana
    Aggarwal, Diwakar
    Barwal, Tushar Singh
    Jain, Aklank
    Kaur, Ginpreet
    Sak, Katrin
    Varol, Mehmet
    Bishayee, Anupam
    SEMINARS IN CANCER BIOLOGY, 2022, 80 : 256 - 275
  • [24] Autophagy in Cancer Therapy-Molecular Mechanisms and Current Clinical Advances
    Ganzleben, Ingo
    Neurath, Markus F.
    Becker, Christoph
    CANCERS, 2021, 13 (21)
  • [25] The metastasizing mechanisms of lung cancer: Recent advances and therapeutic challenges
    Xie, Shimin
    Wu, Zhengguo
    Qi, Yi
    Wu, Binhua
    Zhu, Xiao
    BIOMEDICINE & PHARMACOTHERAPY, 2021, 138
  • [26] Lung Pneumonitis and Fibrosis in Cancer Therapy: A Review on Cellular and Molecular Mechanisms
    Xu, Chaofeng
    Shang, Zhongtu
    Najafi, Masoud
    CURRENT DRUG TARGETS, 2022, 23 (16) : 1505 - 1525
  • [27] Recent advances in the systemic therapy of cancer
    Harrington, J.
    Evans, T. R. J.
    JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF EDINBURGH, 2009, 39 (02) : 134 - 137
  • [28] Molecular mechanisms of astragaloside-IV in cancer therapy (Review)
    Chen, Tianqi
    Yang, Peiying
    Jia, Yingjie
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2021, 47 (03)
  • [29] Emerging cellular and molecular mechanisms underlying anticancer indications of chrysin
    Talebi, Marjan
    Talebi, Mohsen
    Farkhondeh, Tahereh
    Simal-Gandara, Jesus
    Kopustinskiene, Dalia M.
    Bernatoniene, Jurga
    Samarghandian, Saeed
    CANCER CELL INTERNATIONAL, 2021, 21 (01)
  • [30] A comprehensive view on the apigenin impact on colorectal cancer: Focusing on cellular and molecular mechanisms
    Daneshvar, Siamak
    Zamanian, Mohammad Yasin
    Ivraghi, Mehraveh Sadeghi
    Golmohammadi, Maryam
    Modanloo, Mona
    Kamiab, Zahra
    Pourhosseini, Seyed Mohammad Ebrahim
    Heidari, Mahsa
    Bazmandegan, Gholamreza
    FOOD SCIENCE & NUTRITION, 2023, 11 (11): : 6789 - 6801